Lung Cancer

Lung Cancer News

  • ASCO PD-1 Agent 'Breaks Ceiling' in Cancer Immunotherapy A new approach to immune therapy produced durable responses in patients with advanced melanoma, renal cancer, and nonsmall-cell lung cancer.
    Medscape Medical News, June 2, 2012
  • Sorafenib Fails Another Phase 3 Trial in Lung Cancer Sorafenib Fails Another Phase 3 Trial in Lung Cancer The targeted agent has been investigated in several phase 3 trials of nonsmall-cell lung cancer, but none have been successful. The targeted agent has been investigated in several phase 3 trials of nonsmall-cell lung cancer, but none have been successful.
    Medscape Medical News, May 24, 2012
More
 

Lung Cancer Perspectives

  • Watson: The Next Cancer Breakthrough? Watson: The Next Cancer Breakthrough?   Dr. Mark Kris explores ways in which Watson, the IBM supercomputer of Jeopardy! fame, may revolutionize cancer management, reimbursement, and healthcare as a whole.
    Medscape Hematology-Oncology, May 29, 2012
  • Lung Cancer: New Drugs, Emerging Therapies Lung Cancer: New Drugs, Emerging Therapies   Dr. Mark Kris highlights new developments in lung cancer -- including targeted therapies for small cell carcinoma and promising immunotherapies -- to be presented at ASCO® 2012.
    Medscape Hematology-Oncology, May 24, 2012
More
 

Journals

More
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC. This website also contains material copyrighted by 3rd parties.